TMBR insider transactions
Timber Pharmaceuticals Inc. (TMBR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TMBR
- SEC Form 4: Koconis John was granted 70,385 shares, increasing direct ownership by 17,596% to 70,785 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Mendelsohn Alan was granted 35,193 shares, increasing direct ownership by 17,596% to 35,393 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Lucchese Joseph was granted 35,193 shares4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Koconis John4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Gaal Lubor4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Mendelsohn Alan4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Pirozzi Gianluca4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Sitar Edward J4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Cohen David E4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Lucchese Joseph4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Sitar Edward J was granted 2,500 shares, increasing direct ownership by 76% to 5,800 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Lucchese Joseph4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Mendelsohn Alan4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Koconis John4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Cohen David E was granted 100,000 shares4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Sitar Edward J was granted 150,000 shares, increasing direct ownership by 1,000% to 165,000 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Pirozzi Gianluca was granted 100,000 shares4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Gaal Lubor was granted 100,000 shares4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Rome Zachary exercised 79,326 shares at a strike of $0.01 and covered exercise/tax liability with 19,630 shares to satisfy withholding obligation4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Koconis John bought $7,686 worth of shares (20,000 units at $0.38)4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Mendelsohn Alan bought $4,700 worth of shares (10,000 units at $0.47)4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Sitar Edward J bought $6,900 worth of shares (15,000 units at $0.46)4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Lucchese Joseph4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Rome Zachary4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Koconis John4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Tardimed Sciences Llc sold $210,960 worth of Common Stock (225,000 units at $0.94), decreasing direct ownership by 6% to 3,508,567 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Tardimed Sciences Llc sold $368,266 worth of Common Stock (400,500 units at $0.92), decreasing direct ownership by 10% to 3,733,567 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Tardimed Sciences Llc sold $275,630 worth of Common Stock (300,000 units at $0.92), decreasing direct ownership by 7% to 4,134,067 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: TardiMed Sciences LLC sold $168,170 worth of Common Stock (175,000 units at $0.96), decreasing direct ownership by 4% to 4,434,067 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Gaal Lubor4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Mendelsohn Alan4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Pirozzi Gianluca4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Sitar Edward J4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4 filed by Cohen David E4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: TardiMed Sciences LLC sold $221,480 worth of Common Stock (174,915 units at $1.27), decreasing direct ownership by 4% to 4,609,067 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: TardiMed Sciences LLC sold $750,216 worth of Common Stock (587,250 units at $1.28), decreasing direct ownership by 11% to 4,783,982 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: TardiMed Sciences LLC sold $84,019 worth of Common Stock (66,285 units at $1.27), decreasing direct ownership by 1% to 5,371,232 units4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 4: Mendelsohn Alan bought $4,314 worth of Common Stock (1,988 units at $2.17)4 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)
- SEC Form 3 filed by Alan Mendelsohn3 - Timber Pharmaceuticals, Inc. (0001504167) (Issuer)